Abelson Helper Integration Site 1 (AHI1) Peptide
AHI1
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
-
- Antigène Tous les produits AHI1
- AHI1 (Abelson Helper Integration Site 1 (AHI1))
- Type de proteíne
- Synthetic
- Origine
- Mammifères
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Séquence
- KDSTLRIMDL RILAARKFVG AANYREKIHS TLTPCGTLLF SGSEDGIVYV
- Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of Ahi1 antibody,
Alternative Names: Ahi1 control peptide, Ahi1 antibody Blocking Peptide, Anti-Ahi1 Blocking Peptide, Abelson helper integration site 1 Blocking Peptide, Ahi-1 Blocking Peptide, Ahi1 Blocking Peptide, Ahi1, Ahi-1, Ahi 1, Ahi-1 Blocking Peptide, Ahi 1 Blocking Peptide
-
-
- Indications d'application
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C long term.
-
- Antigène
- AHI1 (Abelson Helper Integration Site 1 (AHI1))
- Synonymes
- AHI1 Peptide, AHI-1 Peptide, JBTS3 Peptide, ORF1 Peptide, dJ71N10.1 Peptide, 1700015F03Rik Peptide, Ahi-1 Peptide, D10Bwg0629e Peptide, Abelson helper integration site 1 Peptide, AHI1 Peptide, ahi1 Peptide, Ahi1 Peptide
- Sujet
- Mutations in the human homolog are associated with Joubert syndrome, an autosomal recessive disorder resulting in severe mental retardation.
- Poids moléculaire
- 120 kDa
-
Vous êtes ici:
